Indications

It’s indicated for active immunization against poliomyelitis caused by poliovirus types 1, 2 and 3 from 2 months of age in infants, children and adults both for primary immunization and for boosters.

Highlights

1. The world’s first single Sabin Inactivated Polio Vaccine, launched in 2014

2. WHO Recommended that every country should have included at least one dose of IPV in the vaccination programs by 2015

3. It’s being registered in India

Specification

0.5 mL/single dose ,  contains Type 1 (Sabin) ≤30 D-antigen units; 

Type 2 (Sabin) ≤32 D-antigen units; 

Type 3 (Pfizer) ≤45 D-antigen units.

Dosage form

Liquid

Route of Administration

 Intramuscular injection

Shelf life

24 Months